← back to search

Wende Li

Sun Yat-sen University Cancer Center · CN
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer research, Immunotherapy, Medicine, Biology, Immune system, and Teniposide.
h-index
citations
1,131
works
10
NIH funding
primary concept
email

Recent publications

Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis
Molecular Cancer 2025cited by 24position: middledoi
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Cancer Research 2023cited by 81position: middledoi
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Cell Research 2022cited by 172position: middledoi
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
Signal Transduction and Targeted Therapy 2022cited by 79position: middledoi
Polysaccharide from <i>Pycnoporus sanguineus</i> ameliorates dextran sulfate sodium‐induced colitis via helper T cells repertoire modulation and autophagy suppression
Phytotherapy Research 2020cited by 24position: middledoi
The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3
Journal of Biological Chemistry 2020cited by 10position: middledoi
cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
Journal of Clinical Investigation 2019cited by 252position: middledoi
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
Clinical Cancer Research 2019cited by 164position: middledoi
ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
Cell Death and Disease 2019cited by 129position: middledoi
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Journal of Hematology & Oncology 2018cited by 196position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Penghui Zhou · Huaiyin Institute of Technology4 papers (2018–2022)Xiaojun Xia · Zhejiang International Studies University4 papers (2018–2023)Shuangye Liao · Sun Yat-sen University3 papers (2018–2023)Jianeng Zhang · Sun Yat-sen University3 papers (2018–2023)Tiebang Kang · Sun Yat-sen University3 papers (2018–2022)Phei Er Saw · Sun Yat-sen University2 papers (2019–2025)Liping Xu · Wayne State University2 papers (2018–2023)Ziqian Fang · Cardiff University2 papers (2022–2023)Xingjun Dong · China Automotive Engineering Research Institute2 papers (2022–2022)Jingjing He · Southwest Jiaotong University2 papers (2022–2023)Xiaoding Xu · Shanghai Electric (China)2 papers (2019–2025)Siyu Chen · Shanghai Medical College of Fudan University2 papers (2018–2022)Siyu Chen · Sun Yat-sen University Cancer Center2 papers (2022–2025)Han Yang · Shenyang Pharmaceutical University2 papers (2018–2022)Xiuyu Cai · Hebei University of Engineering2 papers (2018–2022)Xinxin Xiong · Northeast Normal University2 papers (2022–2022)Penghui Zhou · Sun Yat-sen University1 papers (2023–2023)Man‐Li Luo · Sun Yat-sen University1 papers (2019–2019)Zexian Liu · Sun Yat-sen University1 papers (2023–2023)Guokai Chen · National Heart Lung and Blood Institute1 papers (2023–2023)